Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid for Immediate Implant Stability
NCT03691467Phase 4Completed
- Start
- Sep 2019
- Primary completion
- Jan 2021
- Modality
- Hydrogel Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hyaluronic acid sodium composite gel for injection in tooth loss (2 arms). Primary endpoint: Implant Stability at 6 months. Started Sep 2019; status: completed.
02
Drugs
hyaluronic acid sodium composite gel for injection
03
Conditions
tooth loss
Beyond the preview
Go deeper on NCT03691467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03691467.